Wellness Index Report, an independent wellness ratings and education platform, has published a new Inside the Index feature recognizing Nefense as a leader in nasal health innovation. The report examines the growing consumer interest in nasal health, respiratory hygiene, and drug-free alternatives to traditional care.
According to the Wellness Index Report, the article reviews emerging research on hypochlorous acid (HOCl), noting its antimicrobial and anti-inflammatory properties and potential uses across respiratory health and infection control. Nefense offers doctor-recommended, ENT-approved, family-friendly HOCl and xylitol-based nasal solutions as a drug-free alternative to over-the-counter sprays. These products are formulated under the direction of Dr. Richard Downs, DDS.
The recognition comes as more consumers seek non-pharmaceutical options for nasal wellness. The full announcement includes additional details and images. Wellness Index Report was founded by Lindsay O'Neill-O’Keefe and aims to help consumers and medical providers identify evidence-informed wellness solutions through expert review, customer feedback, scientific evaluation, and ongoing performance monitoring.
Nefense's products represent a shift toward drug-free respiratory care, particularly amid increased awareness of respiratory health. The company's use of hypochlorous acid—a compound naturally produced by the body's immune cells—offers a novel approach to maintaining nasal hygiene without the side effects associated with some medicated sprays.
For more information, visit the Wellness Index Report website.
